For information on Exhibiting or Sponsoring this event please contact Jeanne Torbett, CMP, CMMM, Executive Director, at 904-765-7004.
The administration and the Congress are currently discussing various proposals to reform drug pricing policy. Drug prices, as listeners are likely well aware, have risen substantially over the past two decades. For example, between 1997 and 2007 they tripled and currently year-over-year Medicare Part D drug spending is expected to grow through 2026 at twice the 2007 through 2013 growth rate... Read Full Article
TARGET study should fill in the clinical gaps ORLANDO — Evidence continues to grow supporting the concept that reducing inflammation in patients with rheumatoid arthritis (RA) will not only improve their articular symptoms but also lower their cardiovascular (CV) risk, a researcher said at the annual meeting of the Florida Society of Rheumatology here.